Communiqués Hofseth BioCare ASA

Actions

HBC

NO0010598683

Transformation des aliments

Marché Fermé - Oslo Bors 16:45:00 21/08/2026			Varia. 5j.	Varia. 1 janv.
1,345 ^NOK	+2,28%		+1,13%	+1,89%

21/08	Hofseth BioCare ASA publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026	CI
27/07	Hofseth BioCare ASA publie une étude clinique évaluée par des pairs sur le ProGo, démontrant des bénéfices liés au GLP-1 et une augmentation de la masse musculaire maigre	CI

Communiqués

21/08	Hofseth BioCare ASA: SECOND QUARTER 2026 FINANCIAL REPORT	GL
07/08	Notification of Major Holdings	GL
06/08	NOTIFICATION OF MAJOR SHAREHOLDINGS	GL
06/08	HOFSETH BIOCARE ASA: NEW SHARE CAPITAL REGISTERED	GL
31/07	Hofseth Biocare ASA: Notification of major shareholdings	GL
30/07	HOFSETH BIOCARE ASA: EXTRAORDINARY GENERAL MEETING COMPLETED	GL
30/07	HOFSETH BIOCARE ASA: EXTRAORDINARY GENERAL MEETING COMPLETED	AQ
27/07	Hofseth BioCare ASA: NEW PEER-REVIEWED CLINICAL STUDY ON PROGO® PUBLISHED IN BIOMEDICINES DEMONSTRATES GLP-1 BENEFITS AND AN INCREASE LEAN MUSCLE MASS	GL
09/07	HOFSETH BIOCARE ASA: NOTICE OF EXTRAORDINARY GENERAL MEETING	GL
07/07	HOFSETH BIOCARE ASA: MAJOR SHAREHOLDER NOTIFICATION	GL
03/07	HOFSETH BIOCARE ASA: NEW SHARE CAPITAL REGISTERED	GL
30/06	HOFSETH BIOCARE ASA: ANNUAL GENERAL MEETING COMPLETED	GL
30/06	HOFSETH BIOCARE ASA: FIRST QUARTER 2026 FINANCIAL REPORT AND NEW COMMERCIAL UPDATE FOR CURRENT TRADING	GL
29/06	HOFSETH BIOCARE ASA: MANDATORY NOTIFICATION OF TRADE	GL
29/06	HOFSETH BIOCARE ASA: DISCLOSURES OF LARGE SHAREHOLDINGS	GL
29/06	HOFSETH BIOCARE ASA – VOTING UNDERTAKINGS SECURED IN RELATION TO PRIVATE PLACEMENT AND B-SHARE AMENDMENTS	GL
28/06	HOFSETH BIOCARE ASA: PRIVATE PLACEMENT SUCCESSFULLY PLACED	GL
26/06	HOFSETH BIOCARE ASA: CONTEMPLATED PRIVATE PLACEMENT	GL
09/06	Hofseth Biocare ASA: NOTICE OF ANNUAL GENERAL MEETING 2026	GL
22/05	Hofseth BioCare ASA: EXCLUSIVE LICENSE AND SUPPLY AGREEMENT SIGNED FOR PROGO FOR OVER $5M	GL
14/04	Hofseth BioCare ASA: HBC publishes paradigm-changing clinical trial results of OmeGo full spectrum omegas	GL
27/03	Hofseth BioCare ASA: HBC ANNUAL REPORT 2025	GL
13/02	Hofseth BioCare ASA: FOURTH QUARTER 2025 FINANCIAL REPORT	GL
11/02	Notification of major shareholdings	GL
15/12	Hofseth BioCare ASA: Cancellation of Subsequent Offering – Update on completion of Private Placement	GL